Cite
Komiyama K, Tejima T, Tanabe Y, et al. The impact of Rho-kinase inhibitor, "Fasudil", intracoronary bolus administration to improve refractory coronary vasospasm. Cardiovasc Interv Ther. 2011;26(3):281-5doi: 10.1007/s12928-011-0071-2.
Komiyama, K., Tejima, T., Tanabe, Y., Nishimura, T., Kitamura, K., Watanabe, T., Shimada, H., Iwasawa, J., Matsushita, N., Ishikawa, T., Hojo, R., Hayashi, T., Nakai, M., Yoshimura, H., Tatsumoto, A., Fukamizu, S., & Sakurada, H. (2011). The impact of Rho-kinase inhibitor, "Fasudil", intracoronary bolus administration to improve refractory coronary vasospasm. Cardiovascular intervention and therapeutics, 26(3), 281-5. https://doi.org/10.1007/s12928-011-0071-2
Komiyama, Kota, et al. "The impact of Rho-kinase inhibitor, "Fasudil", intracoronary bolus administration to improve refractory coronary vasospasm." Cardiovascular intervention and therapeutics vol. 26,3 (2011): 281-5. doi: https://doi.org/10.1007/s12928-011-0071-2
Komiyama K, Tejima T, Tanabe Y, Nishimura T, Kitamura K, Watanabe T, Shimada H, Iwasawa J, Matsushita N, Ishikawa T, Hojo R, Hayashi T, Nakai M, Yoshimura H, Tatsumoto A, Fukamizu S, Sakurada H. The impact of Rho-kinase inhibitor, "Fasudil", intracoronary bolus administration to improve refractory coronary vasospasm. Cardiovasc Interv Ther. 2011 Sep;26(3):281-5. doi: 10.1007/s12928-011-0071-2. Epub 2011 Jun 18. PMID: 24122598.
Copy
Download .nbib